These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4113518)

  • 41. Immunological study on Hodgkin's disease with special reference to lymphocyte inhibitor.
    Chen YC; Deng JS
    Taiwan Yi Xue Hui Za Zhi; 1981 Jan; 80(1):55-67. PubMed ID: 6946189
    [No Abstract]   [Full Text] [Related]  

  • 42. Immunological responsiveness against two primary antigens in untreated patients with Hodgkin's disease.
    Gast GC; Halie MR; Nieweg HO
    Eur J Cancer (1965); 1975 Apr; 11(4):217-24. PubMed ID: 1095376
    [No Abstract]   [Full Text] [Related]  

  • 43. Lymphocyte transformation in malignant lymphomas.
    Papac RJ
    Cancer; 1970 Aug; 26(2):279-86. PubMed ID: 4916021
    [No Abstract]   [Full Text] [Related]  

  • 44. Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from untreated patients with Hodgkin's disease.
    Romagnani S; Del Prete GF; Maggi E; Bellesi G; Biti G; Rossi Ferrini PL; Ricci M
    J Clin Invest; 1983 May; 71(5):1375-82. PubMed ID: 6602150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Prognostic value of determination of the degree of PHA-stimulated blastic transformation of lymphocytes in Hodgkin's disease].
    Pluzańska A
    Pol Arch Med Wewn; 1977 Apr; 57(4):307-11. PubMed ID: 859748
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparative studies of the proportions of T, B and zero lymphocytes and the degrees of blastic transformation of lymphocytes after stimulation by PHA and CON A in patients with Hodgkin's disease.
    Pluzańska A
    Haematol Blood Transfus; 1977; 20():203-7. PubMed ID: 305396
    [No Abstract]   [Full Text] [Related]  

  • 47. PHA dose dependent defect in lymphocyte stimulation and E-rosette-forming cells in untreated Hodgkin's disease.
    Land JM; Litwin J; Bigel P; Oberling F; Mayer S
    Acta Haematol Pol; 1977; 8(2):131-4. PubMed ID: 329629
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A prospective study of the changes in immune status following radiotherapy for Hodgkin's disease.
    van Rijswijk RE; Sybesma JP; Kater L
    Cancer; 1984 Jan; 53(1):62-9. PubMed ID: 6690004
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immune responsiveness in Hodgkin's disease.
    Denton PM
    Br J Cancer Suppl; 1973 Aug; 1():119-27. PubMed ID: 4613371
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitation of immunocompetence in Hodgkin's disease.
    Faguet GB
    J Clin Invest; 1975 Oct; 56(4):951-7. PubMed ID: 1159096
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased numbers of lymphocytes with single class surface immunoglobulins in Hodgkin's disease.
    Bain GO; Bain VG
    Am J Clin Pathol; 1984 Dec; 82(6):674-7. PubMed ID: 6439030
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The immune response in Hodgkin's disease].
    Schneider M; Schwarzenberg L; Amiel JL; Hayat M; Mascaro G; Otmezguine Y; Mathé G
    Presse Med (1893); 1970 Oct; 78(41):1769-74. PubMed ID: 4097017
    [No Abstract]   [Full Text] [Related]  

  • 53. [Lymphocyte transformation caused by PHA and PPD in patients with Hodgkin's disease and its correlation with clinical and hematological aspects].
    Tognella S; Mantovani G; Malloci A; Del Giacco GS; Manconi PE; Grifoni V
    Haematologica; 1972; 57(9):552-5. PubMed ID: 4199311
    [No Abstract]   [Full Text] [Related]  

  • 54. Inability of leukocytes to stimulate mixed leukocyte reactions.
    Twomey JJ; Douglass CC; Morris SM
    J Natl Cancer Inst; 1973 Aug; 51(2):345-51. PubMed ID: 4271840
    [No Abstract]   [Full Text] [Related]  

  • 55. Prostaglandin-producing suppressor cells in Hodgkin's disease.
    Goodwin JS; Messner RP; Bankhurst AD; Peake GT; Saiki JH; Williams RC
    N Engl J Med; 1977 Nov; 297(18):963-8. PubMed ID: 409950
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lymphocyte transformation by phytohemagglutinin. I. In Hodgkin's Disease.
    Thomas JW; Boldt W; Horrocks G; Low B
    Can Med Assoc J; 1967 Sep; 97(14):832-6. PubMed ID: 6051247
    [No Abstract]   [Full Text] [Related]  

  • 57. Restoration of the reactivity of frozen stored human lymphocytes in the mixed lymphocyte reaction and in response to specific antigens.
    Chess L; Bock GN; Mardiney MR
    Transplantation; 1972 Dec; 14(6):728-33. PubMed ID: 4644133
    [No Abstract]   [Full Text] [Related]  

  • 58. Cell-mediated lympholysis in vitro with normal lymphocytes as target: specificity and cross-reactivity of the test.
    Miggiano VC; Bernoco D; Lightbody J; Trinchieri G; Ceppellini R
    Transplant Proc; 1972 Jun; 4(2):231-7. PubMed ID: 5034149
    [No Abstract]   [Full Text] [Related]  

  • 59. Spontaneous lymphocyte proliferation and depressed cellular immunity in Hodgkin's disease.
    Shiftan TA; Caviles AP; Mendelsohn J
    Clin Exp Immunol; 1978 Apr; 32(1):144-52. PubMed ID: 668190
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tests of immunological competence in lymphogranulomatosis with different antigens in lymphocyte culture.
    Heine KM; Stobbe H
    Helv Med Acta; 1967 Dec; 34(1):36-43. PubMed ID: 5592079
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.